Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Ready
Primary summary from verified readiness
- Confidence
- 78% · stale
- Computed at
- 2026-08-20T10:54:01.450288+00:00
- Claimed
- 70
- Reported
- 68
- Verified
- 63
- Gap
- +7
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-08-20
Track; not yet
- Why
- Cost-per-genome ($80-$100) and scale (60k WGS/yr) are category-leading and real named customers (Regeneron/UK Biobank, Macrogen, Sanger) are deploying the UG-100 base, but the indel/homopolymer error profile, masked-genome regions, and Q2-2026 ship date for the new generation mean it is not yet an adopt-now substrate.
- Next
- Monitor Q2 2026 UG200 shipments and the first independent (non-Illumina) UG200/Solaris-2.0 WGS benchmark; revisit if a multi-omics partner needs population-scale low-cost WGS and homopolymer-region accuracy is non-critical.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 16
- Tier 1
- 2
- Tier 2
- 10
- Tier 3
- 4
- Supports
- 6
- Contradicts
- 4
- Context
- 6
- Latest observed
- 2026-02-01
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-07-19 Reading moved from ready to ready.